SG11201502584XA - Peptides and methods for treating cancer - Google Patents

Peptides and methods for treating cancer

Info

Publication number
SG11201502584XA
SG11201502584XA SG11201502584XA SG11201502584XA SG11201502584XA SG 11201502584X A SG11201502584X A SG 11201502584XA SG 11201502584X A SG11201502584X A SG 11201502584XA SG 11201502584X A SG11201502584X A SG 11201502584XA SG 11201502584X A SG11201502584X A SG 11201502584XA
Authority
SG
Singapore
Prior art keywords
peptides
methods
treating cancer
cancer
treating
Prior art date
Application number
SG11201502584XA
Inventor
Thomas Leonard Joseph
Chandra Shekhar Verma
David Phillip Lane
Christopher John Brown
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG11201502584XA priority Critical patent/SG11201502584XA/en
Publication of SG11201502584XA publication Critical patent/SG11201502584XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11201502584XA 2012-10-01 2013-10-01 Peptides and methods for treating cancer SG11201502584XA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG11201502584XA SG11201502584XA (en) 2012-10-01 2013-10-01 Peptides and methods for treating cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2012073029 2012-10-01
SG11201502584XA SG11201502584XA (en) 2012-10-01 2013-10-01 Peptides and methods for treating cancer
PCT/SG2013/000428 WO2014055039A1 (en) 2012-10-01 2013-10-01 Peptides and methods for treating cancer

Publications (1)

Publication Number Publication Date
SG11201502584XA true SG11201502584XA (en) 2015-05-28

Family

ID=54006453

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502584XA SG11201502584XA (en) 2012-10-01 2013-10-01 Peptides and methods for treating cancer

Country Status (4)

Country Link
US (1) US20150246946A1 (en)
EP (1) EP2904000A4 (en)
SG (1) SG11201502584XA (en)
WO (1) WO2014055039A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160049435A (en) 2014-10-27 2016-05-09 삼성전자주식회사 Composition for reducing cell senescence comprising Atm inhibitor and use thereof
JP7028643B2 (en) * 2015-02-13 2022-03-02 エージェンシー フォー サイエンス， テクノロジー アンド リサーチ P53 activated staple peptide that does not destroy the membrane
KR20160126340A (en) 2015-04-23 2016-11-02 삼성전자주식회사 Three-helix bundle protein and use thereof
US20230330238A1 (en) 2020-10-14 2023-10-19 Dana-Farber Cancer Institute, Inc. Chimeric conjugates for degradation of viral and host proteins and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103508D0 (en) * 2001-02-13 2001-03-28 Univ Dundee Screening method and agents
CA2544223C (en) * 2003-11-05 2017-03-07 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
WO2009149339A2 (en) * 2008-06-05 2009-12-10 University Of Maryland, Baltimore P53 activator peptides
JP2013535514A (en) * 2010-08-13 2013-09-12 エイルロン セラピューティクス，インコーポレイテッド Peptidomimetic macrocycle
WO2012065181A2 (en) * 2010-11-12 2012-05-18 Dana Farber Cancer Institute, Inc. Cancer therapies and diagnostics

Also Published As

Publication number Publication date
EP2904000A1 (en) 2015-08-12
US20150246946A1 (en) 2015-09-03
EP2904000A4 (en) 2016-04-20
WO2014055039A1 (en) 2014-04-10
WO2014055039A9 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
IL288181A (en) Methods of treating cancer
IL267242B (en) Cancer treatment
HK1209798A1 (en) Compositions and methods for treating cancer
EP2836482A4 (en) Compositions and methods for treating cancer
EP2890720A4 (en) Compositions and methods for treating cancer
HK1216854A1 (en) Compositions and methods for treating cancer
HK1210023A1 (en) Cancer treatment
EP2825693A4 (en) Methods and materials for treating cancer
SG11201502584XA (en) Peptides and methods for treating cancer
IL238606A0 (en) Cd44v6--derived peptides for treating metastasizing cancers
EP2841102A4 (en) Methods and compositions for treating cancer
EP2822593A4 (en) Compositions and methods for treating cancer
GB201220901D0 (en) CD44v6-derived peptides for treating pancreatic cancer
GB201222563D0 (en) Cancer treatment
EP2709623A4 (en) Medicaments and methods for treating cancer
SG10201601715YA (en) Novel Pharmaceutical Combinations And Methods For Treating Cancer